Anxiety and Depression in COPD; Prevalence, Detection and Prognosis

Active, not recruiting

• Conditions: Depressive Disorder; COPD; Anxiety Disorders

• Registration Number: NCT04427579
• Lead Sponsor: University Hospital, Akershus

Brief Summary

The current cohort study of 300 stable COPD patients aims to assess the following topics:

* The prevalence of anxiety and depressive disorders in patients with COPD

* The screening properties of Hospital Anxiety and Depression Scale in patients with COPD

* The prognostic influence by anxiety or depressive symptoms and anxiety or depressive disorder.

* whether characterization of 1) affective aspects of dyspnea symptoms or 2) persistent styles of thinking (worry or rumination) and metacognitions that drive these may improve the current recommendation of screening for anxiety and depression in COPD in relation to its clinical relevance on functional status and three year outcome

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-15
• Status Verified: 2020-06
• Study First Submitted: 2020-06-08
• Study First Submitted QC: 2020-06-09
• Last Update Submitted: 2020-06-09
• Study First Posted: 2020-06-11
• Last Update Posted: 2020-06-11
• Primary Completion: 2023-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Participant in in-hospital pulmonary rehabilitation at LHL-hospital Gardermoen
• Diagnosis of COPD

Exclusion Criteria

• Acute exacerbated phase of COPD

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rate	3 years	The number of deaths
COPD exacerbation rate	3 years	The number of moderate or severe exacerbations

Secondary Outcome Measures

Name	Time	Method
Assessment of Health-related Quality of Life With RAND-36	3 years	The total score and subscale scores on RAND 36

Trial Locations

Locations (1)

LHL-hospital Gardermoen; 🇳🇴 Jessheim, Norway